Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,332 | 1,965 | 1,482 | 4,989 | 1,249 |
| Gross Profit | 1,332 | 1,965 | 1,482 | 4,989 | 1,249 |
| Operating Expenses | 43,427 | 39,365 | 33,429 | 34,631 | 29,460 |
| Operating Income | -42,095 | -37,400 | -31,947 | -29,642 | -28,211 |
| Interest Expense | 311 | 317 | 301 | 173 | 0 |
| Other Income | 4,858 | 2,657 | 1,633 | 269 | 111 |
| Pre-tax Income | -37,548 | -35,060 | -30,615 | -29,546 | -28,100 |
| Net Income Continuous | -37,548 | -35,060 | -30,615 | -29,546 | -28,100 |
| Net Income | $-37,548 | $-35,060 | $-30,615 | $-29,546 | $-28,100 |
| EPS Basic Total Ops | -0.67 | -0.69 | -0.65 | -0.82 | -0.78 |
| EPS Basic Continuous Ops | -0.67 | -0.69 | -0.65 | -0.82 | -0.78 |
| EPS Diluted Total Ops | -0.67 | -0.69 | -0.65 | -0.82 | -0.78 |
| EPS Diluted Continuous Ops | -0.67 | -0.69 | -0.65 | -0.82 | -0.78 |
| EBITDA(a) | $-44,227 | $-38,487 | $-32,200 | $-29,012 | $-27,484 |